Abstract:Background: Immunotherapy plays an important role in the treatment of triple-negative breast cancer (TNBC). This study aimed to identify immune-related genes that are associated with the prognosis of patients with TNBC as possible targets of immunotherapy, alongside their related tumor-infiltrating lymphocytes (TILs). Methods: The clinical data and gene expression profiles of patients with breast cancer were extracted from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases and divided into training (n = 1,053) and verification (n = 508) groups. CIBERSORT was used to predict the differences in immune cell infiltration in patient subsets that were stratified according to risk. Gene Ontology (GO) enrichment analysis was used to identify pathways associated with immune-related genes in patient subsets that were stratified according to risk. The clinical data and insulin-like growth factor 2 receptor (IGF2R) expression profiles of patients with breast cancer were extracted from METABRIC. The expression of IGF2R and TILs were evaluated in a cohort containing 282 untreated patients with TNBC. The correlations of IGF2R expression, TILs, and clinicopathological parameters with patient prognosis were analyzed in the whole cohort. Results: The prognostic model, which was composed of 26 immune-related gene pairs, significantly distinguished between high- and low-risk patients. Univariate and multivariate analyses indicated that the model was an independent prognostic factor for breast cancer. Among the identified genes, the expression of IGF2R significantly distinguished between high- and low-risk patients in TCGA ( P = 0.008) and in METABRIC patients ( P < 0.001). The expression of IGF2R was significantly associated with clinical risk factors such as TNBC, estrogen receptor (ER)–negative expression, human epidermal growth factor receptor 2 (HER2)–positive expression, and age ≤60 years old in METABRIC patients. In addition, the patients with IGF2R-positive expression had lower disease-free survival (DFS) rates than those with IGF2R-negative expression in the TNBC cohort (67.8% vs. 78.5%, P = 0.023). IGF2R expression also was significantly negatively correlated with TILs, particularly with CD8 + TILs and CD19 + TILs in the cohort of patients with TNBC. Conclusion: IGF2R can be used as an indicator of a poor prognosis in patients with TNBC and as a potential target and research direction for TNBC immunotherapy in the future.

Expression Patterns of Insulin-Like Growth Factor 1 (Igf-I) and Its Receptor in Mammary Tissues and Their Associations with Breast Cancer Survival

Insulin-like Growth Factor-1 Receptor Gene Expression is Associated with Survival in Breast Cancer: a Comprehensive Analysis of Gene Copy Number, Mrna and Protein Expression

Pan-Cancer Analysis of IGF-1 and IGF-1R as Potential Prognostic Biomarkers and Immunotherapy Targets

Igfbp3 Mrna Expression in Benign and Malignant Breast Tumors

Associations Between Circulating Insulin-Like Growth Factor 1 and Mortality in Women With Invasive Breast Cancer.

Differential expression of the insulin-like growth factor receptor among early breast cancer subtypes.

Expression of Insulin-Like Growth Factor Receptor-1 in Breast Cancer and Its Clinical Significance

Prognostic significance of IGF-1R expression in patients treated with breast-conserving surgery and radiation therapy

Role and its significance of IGF-1 on evolvement of breast cancer

Insulin-like growth factor 2 receptor is a key immune-related gene that is correlated with a poor prognosis in patients with triple-negative breast cancer: A bioinformatics analysis

The Expression Difference Of Insulin-Like Growth Factor 1 Receptor In Breast Cancers With Or Without Diabetes

Expression and Clinical Significance of Insulin-Like Growth Factor 1 in Lung Cancer Tissues and Perioperative Circulation from Patients with Non-Small-cell Lung Cancer.

Expression and Clinical Significance of IGF-I and IGF-IR in Colorectal Cancer

Phenotypes and Genotypes of Insulin-Like Growth Factor 1, IGF-binding Protein-3 and Cancer Risk: Evidence from 96 Studies.

Insulin-like Growth Factor-I Gene Polymorphism and Breast Cancer Risk in Chinese Women.

Insulin-Like Growth Factor Receptor 1 (Igf1r) Expression And Survival In Non-Small Cell Lung Cancer Patients: A Meta-Analysis

Risk Factors for Breast Cancer and Expression of Insulin-Like Growth Factor-2 (IGF-2) in Women with Breast Cancer in Wuhan City, China.

Impact of Phosphorylated Insulin-Like Growth Factor-1 Receptor on the Outcome of Breast Cancer Patients and the Prognostic Value of Its Alteration During Neoadjuvant Chemotherapy.

Association of Preoperative Serum Igf- I Concentration with Clinicopathological Parameters in Patients with Non-Small Cell Lung Cancer

High IGF2 Expression is Associated with Poor Clinical Outcome in Human Ovarian Cancer

Assessment of Insulin-Like Growth Factors and Mutagen Sensitivity As Predictors of Lung Cancer Risk.